• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种用于模拟髓鞘疾病的人诱导多能干细胞来源的三维髓鞘球体平台。

Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases.

作者信息

Feng Lizhao, Chao Jianfei, Zhang Mingzi, Pacquing Elizabeth, Hu Weidong, Shi Yanhong

机构信息

Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Road, Duarte, CA 91010, USA.

Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou, Zhejiang 325000, China.

出版信息

iScience. 2023 Sep 25;26(11):108037. doi: 10.1016/j.isci.2023.108037. eCollection 2023 Nov 17.

DOI:10.1016/j.isci.2023.108037
PMID:37867939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10589867/
Abstract

Myelin defects cause a collection of myelin disorders in the brain. The lack of human models has limited us from better understanding pathological mechanisms of myelin diseases. While human induced pluripotent stem cell (hiPSC)-derived spheroids or organoids have been used to study brain development and disorders, it has been difficult to recapitulate mature myelination in these structures. Here, we have developed a method to generate three-dimensional (3D) myelin spheroids from hiPSCs in a robust and reproducible manner. Using this method, we generated myelin spheroids from patient iPSCs to model Canavan disease (CD), a demyelinating disorder. By using CD patient iPSC-derived myelin spheroids treated with N-acetyl-aspartate (NAA), we were able to recapitulate key pathological features of the disease and show that high-level NAA is sufficient to induce toxicity on myelin sheaths. Our study has established a 3D human cellular platform to model human myelin diseases for mechanistic studies and drug discovery.

摘要

髓鞘缺陷会引发一系列脑部髓鞘疾病。缺乏人类模型限制了我们对髓鞘疾病病理机制的深入理解。虽然人类诱导多能干细胞(hiPSC)来源的球体或类器官已被用于研究大脑发育和疾病,但在这些结构中很难重现成熟的髓鞘形成过程。在此,我们开发了一种方法,能够以稳健且可重复的方式从hiPSC生成三维(3D)髓鞘球体。利用该方法,我们从患者诱导多能干细胞中生成了髓鞘球体,用于模拟一种脱髓鞘疾病——卡纳万病(CD)。通过使用经N - 乙酰天门冬氨酸(NAA)处理的CD患者诱导多能干细胞来源的髓鞘球体,我们能够重现该疾病的关键病理特征,并表明高水平的NAA足以对髓鞘鞘膜产生毒性。我们的研究建立了一个3D人类细胞平台,用于模拟人类髓鞘疾病,以进行机制研究和药物发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/1e0c6d35eb64/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/5ccd3874719b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/dcc20052a1fb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/4a46276731c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/ec8a51a7db6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/8b536f56dfc7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/fb157cb473fe/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/1e0c6d35eb64/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/5ccd3874719b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/dcc20052a1fb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/4a46276731c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/ec8a51a7db6d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/8b536f56dfc7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/fb157cb473fe/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a5/10589867/1e0c6d35eb64/gr6.jpg

相似文献

1
Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases.开发一种用于模拟髓鞘疾病的人诱导多能干细胞来源的三维髓鞘球体平台。
iScience. 2023 Sep 25;26(11):108037. doi: 10.1016/j.isci.2023.108037. eCollection 2023 Nov 17.
2
Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders.开发低免疫原性的人诱导多能干细胞源性少突胶质前体细胞作为治疗髓鞘疾病的现货细胞疗法。
Adv Sci (Weinh). 2023 Aug;10(23):e2206910. doi: 10.1002/advs.202206910. Epub 2023 Jun 4.
3
Chemically Defined Production of Tri-Lineage Human iPSC-Derived Cardiac Spheroids.化学定义法生产三系人诱导多能干细胞来源的心脏类器官。
Curr Protoc. 2023 May;3(5):e767. doi: 10.1002/cpz1.767.
4
Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs.使用人诱导多能干细胞衍生的神经前体细胞和少突胶质前体细胞治疗Canavan病的细胞疗法。
Adv Sci (Weinh). 2020 Oct 29;7(23):2002155. doi: 10.1002/advs.202002155. eCollection 2020 Dec.
5
Aligned Brain Extracellular Matrix Promotes Differentiation and Myelination of Human-Induced Pluripotent Stem Cell-Derived Oligodendrocytes.脑外基质排列促进人诱导多能干细胞源性少突胶质细胞的分化和髓鞘形成。
ACS Appl Mater Interfaces. 2019 May 1;11(17):15344-15353. doi: 10.1021/acsami.9b03242. Epub 2019 Apr 22.
6
3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.三维脑类器官源自多能干细胞:用于脑发育和神经退行性疾病的有前景的实验模型。
J Biomed Sci. 2017 Aug 20;24(1):59. doi: 10.1186/s12929-017-0362-8.
7
Modeling Herpes Simplex Virus 1 Infections in Human Central Nervous System Neuronal Cells Using Two- and Three-Dimensional Cultures Derived from Induced Pluripotent Stem Cells.利用诱导多能干细胞衍生的二维和三维培养物模拟人中枢神经系统神经元细胞中的单纯疱疹病毒 1 感染。
J Virol. 2019 Apr 17;93(9). doi: 10.1128/JVI.00111-19. Print 2019 May 1.
8
Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.用于神经退行性疾病建模的源自诱导多能干细胞的脑类器官技术的发展:概览
Front Mol Neurosci. 2023 Aug 3;16:1173433. doi: 10.3389/fnmol.2023.1173433. eCollection 2023.
9
Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.一种用于优化人诱导多能干细胞衍生心肌细胞分布和保留的移植注射装置的开发。
J Heart Lung Transplant. 2019 Feb;38(2):203-214. doi: 10.1016/j.healun.2018.11.002. Epub 2018 Nov 15.
10
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.一种使用诱导多能干细胞衍生的皮质神经球的多参数钙信号筛选平台。
SLAS Discov. 2022 Jun;27(4):209-218. doi: 10.1016/j.slasd.2022.01.003. Epub 2022 Jan 31.

引用本文的文献

1
Emerging brain organoids: 3D models to decipher, identify and revolutionize brain.新兴的脑类器官:用于解读、识别和变革大脑的三维模型。
Bioact Mater. 2025 Feb 12;47:378-402. doi: 10.1016/j.bioactmat.2025.01.025. eCollection 2025 May.
2
Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis.用于探索进展性多发性硬化症疾病机制的脑类器官方法
Front Cell Neurosci. 2024 Dec 18;18:1488691. doi: 10.3389/fncel.2024.1488691. eCollection 2024.
3
Towards a Treatment for Leukodystrophy Using Cell-Based Interception and Precision Medicine.

本文引用的文献

1
Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model.CLU 风险等位基因介导的星形胶质细胞反应抑制人 iPSC 模型中的少突胶质前体细胞增殖和髓鞘形成。
Cell Rep. 2023 Aug 29;42(8):112841. doi: 10.1016/j.celrep.2023.112841. Epub 2023 Jul 25.
2
Context matters: hPSC-derived microglia thrive in a humanized brain environment in vivo.背景很重要:人多能干细胞衍生的小胶质细胞在体内的人类化大脑环境中茁壮成长。
Cell Stem Cell. 2023 Jul 6;30(7):909-910. doi: 10.1016/j.stem.2023.05.013.
3
Pushing the boundaries of brain organoids to study Alzheimer's disease.
采用基于细胞的截获和精准医学治疗脑白质营养不良。
Biomolecules. 2024 Jul 17;14(7):857. doi: 10.3390/biom14070857.
4
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.诱导多能干细胞和类器官在推进神经病理学研究和治疗中的应用。
Cells. 2024 Apr 25;13(9):745. doi: 10.3390/cells13090745.
5
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.诱导多能干细胞(iPSCs):诱导的分子机制与应用。
Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0.
6
Identity and Maturity of iPSC-Derived Oligodendrocytes in 2D and Organoid Systems.iPSC 衍生少突胶质细胞在 2D 系统和类器官系统中的鉴定和成熟。
Cells. 2024 Apr 13;13(8):674. doi: 10.3390/cells13080674.
7
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.天冬氨酸酰基转移酶的细胞和分子机制及其在卡纳万病中的作用。
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
8
Myelin organoids for the study of Alzheimer's disease.用于阿尔茨海默病研究的髓鞘类器官
Front Neurosci. 2023 Oct 24;17:1283742. doi: 10.3389/fnins.2023.1283742. eCollection 2023.
推动脑类器官研究阿尔茨海默病的边界。
Trends Mol Med. 2023 Aug;29(8):659-672. doi: 10.1016/j.molmed.2023.05.007. Epub 2023 Jun 21.
4
Modeling brain macrophage biology and neurodegenerative diseases using human iPSC-derived neuroimmune organoids.利用人诱导多能干细胞衍生的神经免疫类器官对脑巨噬细胞生物学和神经退行性疾病进行建模。
Front Cell Neurosci. 2023 Jun 5;17:1198715. doi: 10.3389/fncel.2023.1198715. eCollection 2023.
5
Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders.开发低免疫原性的人诱导多能干细胞源性少突胶质前体细胞作为治疗髓鞘疾病的现货细胞疗法。
Adv Sci (Weinh). 2023 Aug;10(23):e2206910. doi: 10.1002/advs.202206910. Epub 2023 Jun 4.
6
Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type gene.利用导入野生型基因的患者诱导多能干细胞进行卡纳万病的治疗性开发。
iScience. 2022 May 11;25(6):104391. doi: 10.1016/j.isci.2022.104391. eCollection 2022 Jun 17.
7
Human IPSC-Derived Model to Study Myelin Disruption.人类诱导多能干细胞衍生模型用于研究髓鞘破坏。
Int J Mol Sci. 2021 Aug 31;22(17):9473. doi: 10.3390/ijms22179473.
8
Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.在血清暴露下的人类脑类器官中模拟散发性阿尔茨海默病。
Adv Sci (Weinh). 2021 Sep;8(18):e2101462. doi: 10.1002/advs.202101462. Epub 2021 Aug 2.
9
Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer's disease.增强髓鞘更新可逆转阿尔茨海默病小鼠模型的认知功能障碍。
Neuron. 2021 Jul 21;109(14):2292-2307.e5. doi: 10.1016/j.neuron.2021.05.012. Epub 2021 Jun 7.
10
Glial Cells Promote Myelin Formation and Elimination.神经胶质细胞促进髓鞘形成与清除。
Front Cell Dev Biol. 2021 May 11;9:661486. doi: 10.3389/fcell.2021.661486. eCollection 2021.